有对比剂所致过敏反应史患者行全身麻醉:一种有效的预防措施吗?
该综述讨论有对比剂所致过敏反应史患者再次使用对比剂时的预防策略,重点评价全身麻醉作为预防措施的价值,指出其费用高、对机体有负担且缺乏客观验证,并提出安全的个体化管理建议。
要点
- 约2%接受碘对比剂的患者出现超敏反应,有反应史者再暴露风险增高。
- 有反应史者目前接受抗过敏药物注射或全身麻醉等预防措施。
- 全身麻醉作为预防措施费用高、对机体有负担且缺乏客观验证。
核心结论
- 全身麻醉作为对比剂过敏反应预防措施费用高、对机体有负担且缺乏客观验证,综述旨在讨论背景与既往实践并提出安全的个体化管理建议。
研究设计与样本
- 综述论文,检索范围与纳入文献原文未报告。
诊断标准与关键数值
- 约2%接受碘对比剂的患者出现超敏反应。
临床应用与阅片要点
- 有对比剂所致过敏反应史的患者再次暴露风险增高,目前接受抗过敏药物注射或全身麻醉等预防措施。
- 作者提出针对个体患者的安全管理建议,原文未给出具体推荐条款。
局限性
- 全身麻醉作为预防措施缺乏客观验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Contrast-enhanced radiological examinations are important diagnostic tools in modern medicine. Currently, all approved and available iodinated and gadolinium-based contrast agents are safe and well-tolerated by most patients. However, approximately 2% of patients receiving iodinated contrast media exhibit hypersensitivity reactions. Patients with a history of such a reaction are at increased risk upon reexposure. Therefore, they are subjected to a prophylaxis such as injection of antiallergy drugs or general anaesthesia. The latter procedure is expensive, can burden the patients organism, and besides lacks objective verification. Therefore, the purpose of our review paper is to present and discuss the background and the previous practice, as well as to provide a proposal for a safe individual patient management.
引用
- Boehm I, Nairz K, Morelli J, et al. General anaesthesia for patients with a history of a contrast medium-induced anaphylaxis: a useful prophylaxis? Br J Radiol. 2017. PMID: 28876979. doi:10.1259/bjr.20160647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。